The following content is translated from Chinese source by machine translation without post-editing.
In April of this year, TalkingChina launched a translation cooperation with Suzhou Jinyi for system certification.
Jiangsu Meifengli Medical Technology Co., Ltd. is a comprehensive large animal experimental center specializing in preclinical experimental research of medical devices. Suzhou Jinyi Medical Technology Co., Ltd., a globally leading new laboratory in hardware conditions, is located in the Suzhou Industrial Park in Jiangsu Province, with a 4700 square meter independent building.
As a public service platform for medical research based on large animal experiments, Meifengli and Suzhou Jinyi can not only provide preclinical animal experiment and in vitro testing research reports required for medical device registration, talent training for new medical technologies and clinical techniques of new devices, but also provide comprehensive preclinical evaluation services such as non clinical pathology, basic medical research evaluation, pharmacological and toxicological evaluation of drug device combination products, stem cells and other drugs.
As a leading translation service provider in the pharmaceutical and medical industry, TalkingChina has a professional translation team covering over 80 languages worldwide, including English, Japanese, Korean, French, German, Spanish, Portuguese, etc. It has maintained good cooperation with major biopharmaceutical and medical device companies for a long time. The cooperating units include but are not limited to: Siemens, Eppendorf AG, Santen, Sartorius, Jiahui Health, Charles River, Huadong Medicine, Shenzhen Samii Medical Center, United Imaging, CSPC, Innolcon, EziSurg Medical, parkway, etc.
In future collaborations, TalkingChina will continue to provide customers with the best language solutions with its rich industry experience.
Post time: Jul-26-2024